HP8 FINANCIAL IMPACT OF A PRIOR-AUTHORIZATION RESTRICTION FOR PIMECROLIMUS 1 CREAM IN THE TREATMENT OF ATOPIC DERMATITIS
May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62589-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)62589-2/fulltext
Section Title :
Section Order :
27
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62589-2&doi=10.1016/S1098-3015(10)62589-2